Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 9, 1998, Pages 857-864

  Konturek, J W ^a   Konturek, S J ^b   Stachura, J ^b   Domschke, W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; LANZUL; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ADAPTATION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DNA SYNTHESIS; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH INJURY;

ADAPTATION, PHYSIOLOGICAL; ADULT; ASPIRIN; CELL DIVISION; DNA; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; GROWTH SUBSTANCES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0031658769     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00385.x     Document Type: Article

References (29)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin like drugs. Nature 1971; 231: 232-5.
2. Ivey KJ. Mechanisms of NSAID-induced gastric damage; actions of therapeutic agents. Am J Med 1988; 84(Suppl. 2A): 41-8.
3. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1991; 92: 94-8.
4. Konturek SJ, Piastucki I, Brzozowski T, Dembinska-Kiec A, Gryglewski R. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981; 80: 4-9.
5. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats - Prevention of gastric necrosis produced by alcohol. HCl. NaOH. hypertonic NaCl and thermal injury. Gastroenterology 1979; 77: 433-43.
6. Rainford KD, Willis C. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effect on prostaglandin production. Dig Dis Sci 1992; 27: 624-35.
7. Konturek PC, Ernst H, Konturek SJ, et al. Mucosal expression of luminal release of epidermal growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut 1997; 40: 463-9.
8. Konturek SJ, Radecki T, Brzozowski T, et al. Gastric cytoprotection by epidermal growth factor. Gastroenterology 1981; 81: 438-43.
9. Bernard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995; 108: 564-80.
10. Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983; 28: 1-6.
11. Konturek JW, Dembinski A, Stoll R, Domschke W, Konturek SJ. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation. Gut 1994; 35: 1197-204.
12. Kelly SM, Crampton J, Hunter JO. Decreased salivary epidermal growth factor in rheumatic disease. A possible mechanism for increased susceptibility to gastric ulceration. Br Med J 1990; 301: 422-3.
13. Eastwood GL, Quimby GF. Effect of chronic aspirin ingestion on epithelial cell proliferation in rat fundus, antrum, and duodenum. Gastroenterology 1982; 82: 852-6.
14. Baumgartner A, Kölz HR, Halter F. Indomethacin and turnover of gastric mucosal cell in the rat. Am J Physiol 1986; 250: G830-5.
15. Levi S, Goodland RA, Lee CY, et al. Inhibitory effect of nonsteroidal antiinflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 356: 840-3.
16. Walt R, Katchinski B, Logan R, Ashleigh J, Langman MJS. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489-92.
17. Konturek JW, Dembinski A, Stachura J, Konturek SJ, Domschke W. Infection of Helicobacter pylori in gastric adaptation to continued aspirin administration in mail. Gastroenterology 1998; 114: 245-255.
18. Schubert TT, Bologna SD, Nensey Y, Schubert AB, Mascha EJ. Ulcer risk factors: Interaction between Helicobacter pylori infection, nonsteroidal use, and age. J Am Med 1997; 94: 413-19.
19. Chan FKL, Sung JJY, Chung SCS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
20. Kordecki H, Kurowski M, Pilecka P, Kosik R. Is Helicobacter pylori infection a risk or protective factor for mucosal lesion development in patients chronically treated with acetylosalicylic acid. J Physiol Pharmacol 1997; 48: 85-91.
21. 13C-urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 1996; 47: 545-58.
22. 2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1981; 24: 89-93.
23. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprophen, aspirin and other nonsteroidal antiinflammatory agents. Am J Med 1984; 77: 19-24.
24. Stachura J, Konturek SJ, Brzozowski T, Konturek JW, Domschke W. Pathologic basis of gastric mucosal adaptation to topical injury. J Gastroenterol 1995; 30: 416-27.
25. Giles KW, Myers A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1965; 206: 93-7.
26. Jankowski J, Al-Rawi JH, Johnson DA, Hopwood D, Filipe MI. Growth regulatory peptides in gastric mucosa. Clin Sci 1942; 82: 581-7.
27. Graham DY, Lacey Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988; 95: 327-33.
28. 2 metabolism. Gut 1992; 33: 164-9.
29. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WDW. Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci 1996; 41: 1583-8.